Xilio plans to present clinical data for vilastobart, a tumor-activated, Fc-enhanced, high affinity binding anti-CTLA-4, and efarindodekin alfa (XTX301), a tumor-activated IL-12, and plans to present ...
MarTech on MSN
Marketing on LinkedIn: What you need to know
Your guide to LinkedIn's tools, strategies and best practices. Updated with information about the new AI ad tools for SMBs. The post Marketing on LinkedIn: What you need to know appeared first on ...
YouTube on MSN
Presentation on point!
Discover the secrets to delivering a presentation that truly hits the mark! In this engaging video, we explore effective ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback